BISOLVON EXPECTORANT 8.25 MG-ML SYRUP 100 ML
DESCRIPTION:
Bisolvon expectorant syrup 100 ml is a medicine to facilitate the expulsion of mucus and relieve cough.
POSOLOGY:
Adults, oral: 4 ml syrup/12-8 h
Children and adolescents <18 years:
Adolescents >12 years: 4 ml of syrup/12-8 h.
Children 6-12 years: 4 ml of syrup/12 h.
Children 2-5 years: 2 ml of syrup/12 h
Children <2 years: contraindicated.
Elderly, oral: no dosage adjustment required.
All our shipments are insured and come with a tracking number.
We will do whatever it takes with excellent customer service to help as we highly value our customers' satisfaction.
Product Information
Product Information
Shipping & Returns
Shipping & Returns

BISOLVON EXPECTORANT 8.25 MG-ML SYRUP 100 ML
BISOLVON EXPECTORANT 8.25 MG-ML SYRUP 100 ML
DESCRIPTION:
Bisolvon expectorant syrup 100 ml is a medicine to facilitate the expulsion of mucus and relieve cough.
POSOLOGY:
Adults, oral: 4 ml syrup/12-8 h
Children and adolescents <18 years:
Adolescents >12 years: 4 ml of syrup/12-8 h.
Children 6-12 years: 4 ml of syrup/12 h.
Children 2-5 years: 2 ml of syrup/12 h
Children <2 years: contraindicated.
Elderly, oral: no dosage adjustment required.
All our shipments are insured and come with a tracking number.
We will do whatever it takes with excellent customer service to help as we highly value our customers' satisfaction.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
DESCRIPTION:
Bisolvon expectorant syrup 100 ml is a medicine to facilitate the expulsion of mucus and relieve cough.
POSOLOGY:
Adults, oral: 4 ml syrup/12-8 h
Children and adolescents <18 years:
Adolescents >12 years: 4 ml of syrup/12-8 h.
Children 6-12 years: 4 ml of syrup/12 h.
Children 2-5 years: 2 ml of syrup/12 h
Children <2 years: contraindicated.
Elderly, oral: no dosage adjustment required.
All our shipments are insured and come with a tracking number.
We will do whatever it takes with excellent customer service to help as we highly value our customers' satisfaction.









